SCHEMBL756100

SCHEMBL756100

Clc1cn2nc(Cl)ccc2n1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
DRD2 P14416 4/20 0.44
DRD4 P21917 4/20 0.44
DRD3 P35462 4/20 0.44
HTR1A P08908 3/20 0.44
ADRA1D P25100 3/20 0.44
ADRA1A P35348 3/20 0.44
ADRA1B P35368 3/20 0.44
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PDE10A Q9Y233 2/20 0.40
AHR P35869 5/20 0.40
DYRK1A Q13627 2/20 0.33
TNF P01375 1/20 0.33
DYRK2 Q92630 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6623486 0.81 KDM4E (0.46) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL1302985 0.81 KDM4E (0.46) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL16118521 0.81 KDM4E (0.46) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL477109 0.81 DYRK1A (0.53) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL20033886 0.81 KDM4E (0.46) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL3357291 0.81 KDM4E (0.46) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL1243656 0.81 ALDH1A1 (0.45) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL3086598 0.78 AHR (0.39) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL297697 0.78 DRD2 (0.52) KDM4EDRD2DRD4DRD3HTR1A
SCHEMBL3951145 0.78 KDM4E (0.40) KDM4EDRD2DRD4DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179092-A1 PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2025-06-05 US disclosed
EP-4490162-A1 PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-01-15 EP disclosed
CN-118843634-A Pyrido [1,2-a ] pyrimidin-4-one derivatives 豪夫迈·罗氏有限公司 2024-10-25 CN disclosed
WO-2023170115-A1 PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2023-09-14 WO disclosed
US-9617271-B2 Triazolo compounds HOFFMANN-LA ROCHE INC. (US) 2017-04-11 US disclosed
EP-2916842-B1 TRIAZOLO COMPOUNDS HOFFMANN LA ROCHE (CH) 2016-10-19 EP disclosed
EP-2916842-A1 TRIAZOLO COMPOUNDS F. Hoffmann-La Roche AG (CH) 2015-09-16 EP disclosed
US-20150232472-A1 TRIAZOLO COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2015-08-20 US disclosed
EP-2430013-B1 HETEROARYL COMPOUNDS AS PIKK INHIBITORS AMGEN INC (US) 2014-10-15 EP disclosed
WO-2014072261-A1 TRIAZOLO COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-05-15 WO disclosed
US-20050032650-A1 Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-02-10 US disclosed
EP-1466527-A1 FUSED HETEROCYCLIC SULFONYLUREA COMPOUND, HERBICIDE CONTAINING THE SAME, AND METHOD OF CONTROLLING WEED WITH THE SAME Sumitomo Chemical Takeda Agro Company, Limited (JP) 2004-10-13 EP disclosed
WO-1997011075-A1 TRIAZOLE COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-03-27 WO disclosed
EP-0381132-B1 Imidazopyridazines, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-03-08 EP disclosed
EP-0238070-B1 Sulfonylurea compounds, their production and herbicidal use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1993-12-29 EP disclosed
US-5202324-A Bronchodilators TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-04-13 US disclosed
US-5155108-A Imidazopyridazines and use as antiasthmatic agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-10-13 US disclosed
US-5017212-A For rice paddies TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-05-21 US disclosed
EP-0381132-A1 Imidazopyridazines, their production and use Takeda Chemical Industries, Ltd. (JP) 1990-08-08 EP disclosed
EP-0238070-A2 Sulfonylurea compounds, their production and herbicidal use Takeda Chemical Industries, Ltd. (JP) 1987-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150232472-A1 TRIAZOLO COMPOUNDS GRIK5, NLN, GRIN2C KDM4E 4142/4885DRD2 1242/4885DRD4 1391/4885
US-20250179092-A1 PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES ADORA1, P2RY1, CCNA1 KDM4E 3894/4885DRD2 236/4885DRD4 197/4885
US-20050032650-A1 Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same NOTUM, WEE1, DDT KDM4E 683/4885DRD2 1082/4885DRD4 1741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.